NCT06157567View on ClinicalTrials.gov

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

May 24, 2027

Study Completion Date

May 24, 2028

Conditions
Skin LaxityWrinkleSkin Condition
Interventions
DEVICE

Profound Matrix

Treatment visits are limited to up to three (3) study treatments (with treatment intervals 6 weeks ± 2 weeks).

Trial Locations (6)

22180

Gerrish MedEsthetics, Vienna

28306

Concierge Medical Arts, Fayetteville

28830

Candela European Institue of Excellence, Madrid

32207

Center for Morden Aesthetic Medicine, Jacksonville

01752

Candela Institue for Excellence, Marlborough

Unknown

Waterfront Skin and Laser, Vancouver

Sponsors
All Listed Sponsors
lead

Candela Corporation

INDUSTRY